Video
Smruthy Sivakumar, PhD, discusses results from a large-scale analysis of ancestry, patterns of gene alterations, comprehensive genomic profiling, and treatment patterns in nearly 12,000 patients with prostate cancer. As genomic and precision medicine studies have historically underrepresented men of African ancestry, Sivakumar et al sought to shed light on disparities in this patient population.
The results were shared in as abstract as part of the 2021 ASCO Annual Meeting (J Clin Oncol 39, 2021 [suppl 15; abstr 5003]). The study was conducted through a partnership between Foundation Medicine and the University of Miami Sylvester Comprehensive Cancer Center.